Aurora Cannabis Inc (ACB) SEC filings

ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 11, 2026Score 6/30

$4.94−0.05 (-1.00%)

Close on Nov 13, 2026Market cap $291.20MP/E –Yield –

SEC filings

40 of Aurora Cannabis's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 9, 2026	Nov 9, 2026	SEC EDGAR
Current report	6-K	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Nov 3, 2026	Nov 4, 2026	SEC EDGAR
Current report	6-K	Nov 3, 2026	Nov 3, 2026	SEC EDGAR
Current report	6-K	Oct 29, 2026	Oct 29, 2026	SEC EDGAR
Current report	6-K	Oct 26, 2026	Oct 26, 2026	SEC EDGAR
Current report	6-K	Oct 14, 2026	Oct 14, 2026	SEC EDGAR
Current report	6-K	Oct 8, 2026	Oct 8, 2026	SEC EDGAR
Current report	6-K	Oct 6, 2026	Oct 7, 2026	SEC EDGAR
Current report	6-K	Oct 5, 2026	Oct 6, 2026	SEC EDGAR
Current report	6-K	Sep 23, 2026	Sep 24, 2026	SEC EDGAR
Current report	6-K	Sep 16, 2026	Sep 16, 2026	SEC EDGAR
Current report	6-K	Sep 14, 2026	Sep 14, 2026	SEC EDGAR
Current report	6-K	Sep 9, 2026	Sep 9, 2026	SEC EDGAR
Current report	6-K	Sep 2, 2026	Sep 2, 2026	SEC EDGAR
Current report	6-K	Aug 24, 2026	Aug 24, 2026	SEC EDGAR
Current report	6-K	Aug 19, 2026	Aug 19, 2026	SEC EDGAR
Current report	6-K	Aug 19, 2026	Aug 19, 2026	SEC EDGAR
Current report	6-K	Aug 13, 2026	Aug 13, 2026	SEC EDGAR
Current report	6-K	Aug 11, 2026	Aug 11, 2026	SEC EDGAR
Current report	6-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	6-K	Aug 10, 2026	Aug 10, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Aug 5, 2026	SEC EDGAR
Current report	6-K	Aug 5, 2026	Aug 5, 2026	SEC EDGAR
Current report	6-K	Jul 27, 2026	Jul 27, 2026	SEC EDGAR
Current report	6-K	Jul 23, 2026	Jul 23, 2026	SEC EDGAR
Current report	6-K	Jul 22, 2026	Jul 23, 2026	SEC EDGAR
Current report	6-K	Jul 9, 2026	Jul 9, 2026	SEC EDGAR
Current report	6-K	Jul 8, 2026	Jul 9, 2026	SEC EDGAR
Current report	6-K	Jul 8, 2026	Jul 8, 2026	SEC EDGAR
Annual report	40-F	Mar 31, 2026	Jun 11, 2026	SEC EDGAR
Current report	6-K	Jun 11, 2026	Jun 11, 2026	SEC EDGAR
Current report	6-K	May 28, 2026	May 28, 2026	SEC EDGAR
Current report	6-K	May 21, 2026	May 21, 2026	SEC EDGAR
Current report	6-K	May 14, 2026	May 14, 2026	SEC EDGAR
Current report	6-K	Apr 28, 2026	Apr 28, 2026	SEC EDGAR
Current report	6-K	Apr 16, 2026	Apr 16, 2026	SEC EDGAR
Current report	6-K	Apr 15, 2026	Apr 15, 2026	SEC EDGAR
Current report	6-K	Mar 30, 2026	Mar 30, 2026	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Aurora Cannabis's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Feb 20, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACB.

Compare: ACB vs CGC · ACB vs CRON · ACB vs CRLBF · ACB vs OGI · ACB vs JUSH

Revenue growth11.0% · median 10.7%

Gross margin42.6% · median 44.2%

Company	Revenue	Growth
ACB	C$320.59M	+11.0%
CGC	C$308.32M	+10.7%
JUSH	$276.54M	+6.2%
CRON	$206.20M	+55.8%
CRLBF	–	–
OGI	–	–

Company

Exchange: Nasdaq
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: March 31
Held by institutions: 8.9%
Auditor: Ernst & Young LLP
SEC CIK: 1683541

Advertisement
300 × 250

See a number that looks wrong?